Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.
Google Scholar · Feb 2026 View Profile →
About
Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.
His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.

Publications
A short selection from 250+ peer-reviewed works across high-impact journals.
Recognition
Stanford/Elsevier List — among the most influential researchers in public health.
Recognised for inspiring research capacity building across Africa.
Top 11 globally for antimicrobial stewardship innovation.
Blog
Thoughts on public health, equity, global health policy, and more.
6 August 2026
A systematic review and meta-analysis of 10 population-based studies and more than 700,000 participants found no statistically clear link between exclusive e-cigarette use and hypertension, while dual use of e-cigarettes and cigarettes was associated with 41% higher odds of prevalent and 35% higher risk of incident high blood pressure.
Read article →9 July 2026
A study of 5,064 adults in the Scottish Health Survey found that current e-cigarette users who were former smokers reported better self-rated health than current cigarette smokers, though perceived health did not clearly vary by time since quitting within the vaping group.
Read article →9 July 2026
A nationally representative study of 13,297 adults aged 60 and over in the Scottish Health Survey found current e-cigarette use was low at 4.5% but strongly concentrated among current and former smokers, declining with age and higher in more deprived areas.
Read article →Contact
I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.